Aims/hypothesis Novel strategies to stimulate the expansion of beta cell mass in situ are warranted for diabetes therapy. The aim of this study was to elucidate the secretome of human bone marrow (BM)-derived multipotent stromal cells (MSCs) with documented islet regenerative paracrine function. We hypothesised that regenerative MSCs will secrete a unique combination of protein factors that augment islet regeneration. Methods Human BM-derived MSCs were examined for glucose-lowering capacity after transplantation into streptozotocin-treated NOD/severe combined immunodeficiency (SCID) mice and segregated into samples with regenerative (MSC R ) vs nonregenerative (MSC NR ) capacity. Secreted proteins associated with islet regenerative function were identified using stable isotope labelling with amino acids in cell culture (SILAC)-based quantitative proteomics. To functionally validate the importance of active Wnt signalling, we stimulated the Wnt-signalling pathway in MSC NR samples during ex vivo expansion using glycogen synthase kinase 3 (GSK3) inhibition (CHIR99201), and the conditioned culture media (CM) generated was tested for the capacity to support cultured human islet cell survival and proliferation in vitro. Results MSC R showed increased secretion of proteins associated with cell growth, matrix remodelling, immunosuppressive and proangiogenic properties. In contrast, MSC NR uniquely secreted proteins known to promote inflammation and negatively regulate angiogenesis. Most notably, MSC R maintained Wnt signalling via Wnt5A/B (~2.5-fold increase) autocrine activity during ex vivo culture, while MSC NR repressed Wnt signalling via Dickkopf-related protein (DKK)1 (~2.5-fold increase) and DKK3 secretion. Inhibition of GSK3 activity in MSC NR samples increased the accumulation of nuclear β-catenin and generated CM that augmented beta cell survival (13% increases) and proliferation when exposed to cultured human islets. Conclusions/interpretation Maintenance of active Wnt signalling within human MSCs promotes the secretion of matricellular and proangiogenic proteins that formulate a niche for islet regeneration. 
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Introduction
In 2013, WHO reported that over 347 million people worldwide lived with diabetes, and estimated that this number will increase to 552 million by 2030, making diabetes a worldwide epidemic [1] . The Edmonton Protocol provided proof-ofconcept that islet transplantation can temporarily reduce insulin dependence in individuals with type 1 diabetes [2] . Although islet replacement is an attractive strategy to combat diabetes, a critical shortage of donor islets and eventual rejection by continuing autoimmunity prevent the widespread application of this approach [3] . Bone marrow (BM)-derived stem cell transplantation has also been reported to promote endogenous islet regeneration in preclinical models, and represents a promising alternative strategy to combat diabetes [4] .
Human multipotent stromal cells (MSCs) have become a focal point in recent clinical trials for tissue repair [5] . MSCs are readily available from autologous or allogenic donors, they are efficiently expanded in culture and they home to damaged tissues to initiate innate repair mechanisms [6] . MSCs exert their therapeutic effects primarily through the secretion of trophic signals within damaged organs, or impact tissue repair from distant sites by secretion of regenerative effectors into the circulation within exosomes or microvesicles [7] . Exosomes harvested from MSCs have been shown to contain proangiogenic proteins and promote the healing of ischaemic tissue [8, 9] . MSCs also secrete a wide variety of immunomodulatory molecules that dampen autoimmunity via modulation of immune cell functions [10, 11] . Currently, the mechanisms underlying the regenerative and immunomodulatory effects of MSCs remain poorly understood, and better understanding of MSC protein secretion is required to harness the true regenerative capacity of MSCs.
In the context of diabetes, transplanted human BM-derived MSCs have been shown to promote repair of pancreatic islets and renal glomeruli in NOD/severe combined immunodeficiency (SCID) mice after beta cell ablation [6] . Although MSC conversion into insulin-expressing beta-like cells has been demonstrated after stable induction of PDX1 [12] , minimally manipulated MSCs did not adopt a beta cell phenotype after transplantation in vivo. In contrast, transplanted MSCs initiated endogenous islet recovery via paracrine stimulation [13] . In a series of publications, we have shown that human BM-derived MSCs stimulated the emergence of small, recipient-derived islet-like structures associated with the ductal epithelial niche within 7 days of injection into streptozotocin (STZ)-treated hyperglycaemic NOD/SCID mice [14, 15] . Unfortunately, MSC samples showed donordependent variability in the capacity to improve glycaemia and prolonged expansion ex vivo reduced islet regenerative prowess [14] . Thus, detailed proteomic analyses of the islet regenerative MSC secretome remain the key to understanding which protein signals promote islet regeneration in situ.
We compared the secretory protein profile of human BMderived MSCs with or without islet regenerative capacity by performing global proteomic analysis of conditioned culture media (CM) after stable isotope labelling with amino acids in cell culture (SILAC) [16] . We hypothesised that islet regenerative MSCs will secrete a combination of unique protein factors that augment islet regeneration. In order to confirm our findings we also examined the effects of exogenous stimulation of Wnt signalling in MSCs for the survival and proliferation of human islet-derived beta cells in vitro. To our knowledge, this is the first proteomic study linking the human MSC secretome profile with beta cell regenerative function and it highlights the importance of active Wnt signalling in the maintenance of MSC-induced islet regeneration.
Methods

MSC
R reduced hyperglycaemia after transplantation in vivo Human BM was obtained from healthy donors after informed consent at the London Health Sciences Centre (London, ON, Canada). All studies were approved by the human ethics committee at Western University (2015-003).
The hyperglycaemia-lowering capacity of six MSC samples was assessed after tail vein injection of 500,000 cells into STZ-treated NOD/SCID mice as previously described [14] . N 2 ] L-lysine were added into SILAC media at 87.8 mg/l and 52.2 mg/l, respectively (Silantes Germany). Excess unlabelled L-proline was added to prevent conversion of heavy arginine into heavy proline [17] . MSCs were grown in SILAC media for 9 days to achieve >95% label incorporation.
Generation of labelled CM and proteomic workflows
MSCs were re-plated in AmnioMax without supplement for 24 h to collect proteins secreted by MSCs. CM was collected in biological and technical duplicate, filtered and concentrated using 3 kDa cut-off filter units (Millipore, Bedford, MA, USA). Total protein (150 μg) was subjected to 1D SDS-PAGE fractionation using 12% gels and quantified using the bicinchoninic acid assay (BCA). All MS data was collected using a QExactive (ThermoFisher Scientific, Waltham, MA, USA). Full MS parameters are outlined in the electronic supplementary material (ESM) Confocal microscopy and flow cytometry for total β-catenin MSCs were cultured in six-well plates on glass cover slips and treated with glycogen synthase kinase 3 (GSK3) inhibitor CHIR99021 (EMD Millipore, Billerica, MA, USA) and stained for nuclear β-catenin. Flow cytometry was used to quantify total cytosolic β-catenin levels after treatment with CHIR99201. See ESM Methods for complete details.
Human islet culture with MSC CM Human islets from five donors were obtained from the Integrated Islet Distribution Program (IIDP). Upon arrival, 200 islet equivalents were plated in RPMI media without serum (Invitrogen). MSC CM was collected after 24 h from MSCs treated with DMSO (basal CM) or with 10 μmol/l of CHIR99021 (GSK3i CM). CM was concentrated using 3 kDa molecular mass cut-off filters, and~1.0 μg/μl total protein was added to human islet culture for 1, 3 or 7 days (ESM Fig. 1 ). After islet harvest and dissociation, beta cell content was estimated using FluoZin-3 (Flz3) (ThermoFisher Scientific) and apoptosis was quantified using 7AAD and Annexin-V. To detect islet cell proliferation, 500 nmol/l of 5-ethynyl-2′-deoxyuridine (EdU) was added to islet culture 24 h prior to harvest. Islets were fixed and permeabilised using 10% formalin and saponin buffer, stained for insulin using a PE-conjugated insulin antibody (R&D Systems, Minneapolis, MN, USA), and nuclear EdU incorporation was detected using the Click-It flow cytometry assay (Life Technologies). Flow cytometry data were analysed using FloJo software (Treestar, Ashland, OR, USA).
Statistical analysis Statistical analysis was performed using GraphPad Prism version 6.01 (GraphPad, La Jolla, CA, USA) by ANOVA with Tukey's post hoc test or by multiple t tests. Data are expressed as means (SEM).
Results
Regenerative capacity of human MSCs was donor specific Hyperglycaemic (15-25 mmol/l), STZ-treated (35 mg/kg per day, days 1-5) NOD/SCID mice were i.v. injected on day 10 with MSCs (5 × 10 5 ) [14, 18] , and blood glucose levels were monitored for 42 days. Compared with PBS-injected control mice, MSC samples (n = 3) that showed significant reduction in systemic blood glucose from days 17-42 were termed MSC R and MSC samples (n = 3) that did not show blood glucose reduction (>25 mmol/l) were termed MSC NR (Fig.  1a ). There was a significant reduction in blood glucose AUC for MSC R vs MSC NR samples (Fig. 1b) [14, 15] . Cell surface phenotype showed that both MSC R and MSC NR expressed the stromal markers CD90 and CD105 (>95%) without expression of the pan-leucocyte marker CD45 (data not shown). MSC donor information, including age, sex, weight and BMI, is shown in Fig. 1c .
MSC
R exclusively secreted proteins associated with active Wnt signalling We have previously shown that MSC R demonstrated increased transcription of matrix metalloproteases, EGF-family ligands and downstream products of Wnt signalling [15] . Here, we sought to confirm and identify secreted protein targets that contribute to islet regeneration by comparing the secretome of MSC R and MSC NR samples using global MS-based proteomics coupled with SILAC. CM was harvested from each MSC line (24 h) and analysed in biological and technical duplicates. The total number of proteins detected for each MSC sample is shown in Fig. 2a . Proteins from each MSC line were combined based on regenerative capacity and complete lists of secreted proteins detected exclusively in CM from MSC R or MSC NR , or proteins common to both groups, were generated (ESM Tables 2-4 ). Of 4665 total proteins detected (false discovery rate 1%), 3023 (~65%) were produced by both MSC R and MSC NR , 850 (~18%) were produced by MSC R exclusively, while 792 (~17%) were produced by MSC NR exclusively (Fig. 2b) . Gene ontology using cellular component analysis revealed that MSC R CM contained qualitatively more proteins with extracellular localisation (21% vs 14%), while MSC NR CM contained more membrane-bound proteins (23% vs 19%) (Fig. 2c) . Moving forward, protein lists were filtered to include only extracellular (secreted) and membrane-bound proteins, and were further analysed for known biological functions and signalling family association. MSC R demonstrated increased representation of secreted proteins associated with angiogenesis and activation of the Wnt-signalling pathway, while MSC NR showed increased secretion of proteins associated with EGF, FGF and Notch signalling pathways (Fig. 2d) . MSC R exclusively secreted several proteins associated with cell survival and growth, such as FGF7 and bone morphogenetic protein (BMP)4. Proangiogenic factors vascular endothelial growth factor receptor 2 (KDR), vascular endothelial growth factor receptor 4 (FLT4) and regulators of angiogenesis A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)13 and 18 were also unique to the MSC R secretome [19] . [20] [21] [22] . In contrast, proteins exclusively detected in MSC NR CM included positive and negative regulators of angiogenesis (FGF receptor (FGFR)4, FLT1) [19, 23] , and an abundance of proinflammatory cytokines (IL-6, IL-8) and C-X-C motif chemokines (CXCL2, 3, 5) ( Table 2 ) [24] . Collectively, these findings suggested MSC R actively secreted cell growth supportive factors with reduced secretion of common proinflammatory signals, and only MSC R showed production of multiple effectors associated with active Wnt signalling. , quantitative proteomics was performed using label-free quantification [16, 25] to identify proteins differentially secreted into serum-containing media. Lists were filtered to include only secreted and membrane-bound proteins, and 1038 common proteins were quantified to generate lists of differentially expressed proteins (ESM Table 5 ). We did not observe any significant difference in the total number of proteins quantified between samples (Fig. 3a) [23, 28] and chemokines involved in cell recruitment (CXCL12) (Fig. 3c) [28, 29] . Thus, the activation of Wnt and proangiogenic signalling again correlated with islet regenerative potency. Conversely, the negative regulator of Wnt signalling Dickkopf-related protein (DKK)1 was increased~2.5-fold in MSC NR CM, and negative regulators of angiogenesis (ADAMTSs, thrombospondin [THBS]1 and THBS2) and inhibitors of matrix remodelling proteins (metalloproteinase inhibitor [TIMP]3) were increased in MSC NR CM [30] . HMVECs were cultured on growth factor-reduced Geltrex to assess the angiogenic potential of MSC CM in vitro (Fig. 3e) . A significant increase in the tubule formation was observed when HMVECs were cultured using CM from MSC R compared with MSC NR . Representative photomicrographs of tube formation after 24 h are shown in ESM Fig. 2 . Finally, we identified that pro-differentiation proteins associated with Notch signalling were upregulated in MSC NR (NOTCH2, JAG-1) [31] , suggesting that inhibited Wnt and angiogenic signalling and activated Notch signalling was associated with diminished islet regenerative capacity. [20, 32] . Taken together, upregulation of Wnt signalling at the mRNA and protein level strongly suggests active Wnt signalling during expansion was a unique and conserved characteristic that correlated with the reduction of hyperglycaemia after transplantation of MSC R in vivo.
MSCs show activation of Wnt signalling via accumulation of nuclear β-catenin Canonical Wnt signalling converges on the actions of β-catenin, a transcription factor that increases the expression of downstream effectors of Wnt signals [33] . We mimicked Wnt signalling in MSC NR and MSC R using a small molecule (CHIR99201) inhibitor of GSK3. GSK3 actively phosphorylates β-catenin, which marks it for ubiquitination and degradation. Therefore, inhibition of GSK3 leads to stabilisation and accumulation of free β-catenin [20] . MSC samples showed maximal increases in total β-catenin using 5-10 μmol/l CHIR99201 for 24-48 h. We then used confocal microscopy to visualise the accumulation of nuclear β-catenin (Fig. 4) . Compared with DMSO control cells (Fig. 4a) , MSC NR and MSC R stimulated with 10 μmol/l CHIR99201 showed increased nuclear β-catenin localisation (Fig. 4b, c) . Next, MSC NR and MSC R samples were analysed in quadruplicate to quantify total β-catenin levels by flow cytometry (Fig. 4d) . Representative dot plots are shown in , and performed multiparametric flow cytometry to analyse beta cell survival and proliferation. Human islets were obtained through the IIDP. Compared with MSC NR CM, human islets grown in MSC R CM showed increased total number of beta cells (Fig. 5a ) and an increased frequency of live beta cells (Fig. 5b ) after 7 days of culture. To further assess the influence of active Wnt signalling on islet regenerative paracrine function, we also assessed whether CM generated by MSC NR treated with a GSK3 inhibitor (CHIR99201) during expansion could promote human beta cell survival or proliferation in cultured human islets. CM recovered from MSC NR cultured with vehicle control (DMSO) only (basal CM) was compared with CM recovered from MSC NR treated with 10 μmol/l CHIR99201 (GSK3i CM) (Fig. 5c) . Five independent human islet samples were cultured as indicated in ESM Fig. 1 . At each time point, human islets were harvested, dissociated with trypsin, and stained using Flz3 to estimate Fold change beta cell frequency, 7AAD to determine cell viability and Annexin-V to determine apoptosis rates by multiparametric flow cytometry. Representative dot plots are shown in ESM Fig. 5 . Compared with basal CM, human islets grown in CM generated by GSK3-inhibited MSC NR showed increased total cell numbers (Fig. 5d) , beta cell numbers (Fig. 5e ) and the proportion of live (7AAD−) beta cells at 7 days culture (Fig.  5f ). However, no significant changes in the frequency of apoptotic beta cells were observed (Fig. 5g) .
To determine whether increased beta cell number was augmented by increased beta cell proliferation in vitro, we measured EdU incorporation in insulin + beta cells. At each time point, human islets were harvested, permeabilised, stained for intracellular insulin and proliferation was detected by EdU incorporation using the Click-It system. Representative dot plots showing EdU+ cell detection for each condition are shown in ESM Fig. 6 . Compared with basal CM, islet exposure to CM generated by GSK3-inhibited MSC NR increased the overall frequency of proliferating cells (Fig. 6a) and proportion of total proliferating beta cells (Fig. 6b) . Finally, islet donor variability was documented by donor information including age, sex, BMI and average blood glucose levels (Fig.   6c) . Collectively, these data suggest that CM generated from MSC NR treated with CHIR99201 promoted beta cell survival and induced beta cell proliferation in vitro.
Discussion
We used comprehensive SILAC-based proteomic analyses to identify MSC-secreted factors that correlated with the capacity to lower circulating blood glucose after transplantation into STZ-treated NOD/SCID mice. MSC R , demonstrated glucose-lowering capacity after transplantation, secreted proteins associated with cell growth, matrix remodelling, immunosuppressive and proangiogenic properties. In contrast, MSC , and improve our understanding of MSC-secreted signals governing islet regeneration. We predict this dataset will aid in the development of future therapies to augment islet regeneration during diabetes.
Functional beta cells secrete proangiogenic proteins responsible for recruiting circulating or tissue resident progenitor cells to islets after damage [34] . However, during autoimmunity or after islet isolation and transplantation these critical functions are likely to be dysregulated, resulting in transient ischaemia that significantly impairs islet function [35] . Increased production of potent proangiogenic factors, such as FGF7, PDGF and VEGFA, by MSC R underscore the functional capacity to generate a proangiogenic microenvironment. Collectively these proteins potently stimulate human islet vascularisation in vitro [36] . To validate the functional relevance of proangiogenic secretory patterns, MSC R CM showed increased capacity to induce spontaneous tubule formation by HMVEC compared with MSC N R CM. Interestingly, MSC NR primarily secreted negative regulators of angiogenesis such as FLT1 and FGFR4, which have both been shown to inhibit the signal cascade mediated by VEGFA [19] . We have previously shown that intrapancreatic transplantation of proangiogenic haematopoietic progenitor cells induced islet revascularisation and beta cell proliferation and augmented systemic insulin release in STZ-treated NOD/ SCID mice [15] . Therefore, our data suggest MSC R may also formulate a proangiogenic microenvironment to support beta cell survival and function within endogenous or transplanted islets.
The prevention of proinflammatory states within damaged islets may also be relevant in the context of MSC therapy for type 1 diabetes. The presence of central mediators of inflammation in CM from MSC NR , such as IL-1β, IL-6 and IL-8, suggests that MSC NR may contribute to a proinflammatory cascades. In people with type 1 diabetes, beta cell destruction is initiated by a combination of proinflammatory cytokines, including IL-1β and IL-6 [37] , and CXCL family chemokines, leading to recruitment of immune effectors that mediate beta cell destruction [38] . Furthermore, high levels of IL-8 have been linked to elevated NEFA, which can signal inflammatory cascades in the pancreas [39] . In contrast, these cytokines and chemokines were not secreted by MSC R . Rather, MSC R secreted cytokines that could potentially reduce inflammation. For example, TGF-β suppresses the secretion of various inflammatory cytokines/chemokines, and induces cytokine secretion patterns that balance local immunity [40] . Stromal cell-derived factor 1 (CXCL12), also upregulated by MSC R , has been shown to directly promote beta cell survival through the activation of AKT [41] . Collectively, we propose MSC R generate a niche with reduced inflammation, improving beta cell survival, while MSC NR contribute to a more deleterious proinflammatory microenvironment.
Inadequate beta cell mass leads to hyperglycaemia in both type 1 and type 2 diabetes. Currently, there is significant interest in restoration of beta cell mass through induction of endogenous regenerative mechanisms in situ using cellular or protein therapies. Our previous transplantation studies suggested that human BM-derived MSCs stimulate an islet regeneration programme with neogenic characteristics. Mice transplanted with MSC R , demonstrated improved glycaemic control via the emergence of small beta cell clusters associated with the ductal epithelium [14] . Several identified effectors may act in synergy to mediate islet regenerative processes. First, MSC R showed increased secretion of EGF previously shown to increase beta cell mass in rodents by stimulating beta cell replication [42] . However, EGF receptor signalling was required for expansion of murine beta cell mass in response to a high-fat diet, but was not crucial for neoislet formation after pancreatic ductal ligation [43] . Second, the CCN family of extracellular matrix-associated, heparin-binding proteins has been shown to modulate cell growth and repair in many tissues by increasing the bioavailability of BMPs, VEGF, Wnt and TGF ligands [44] . More specifically, connective tissue growth factor (CTGF) or CCN2 has been widely studied during beta cell development [45] . Within our dataset, MSC R exclusively secreted CCN5). Previously, we have identified WISP1 (encoding CCN4) and WISP2 (encoding CCN5) mRNA as being upregulated in MSC R [15] . Importantly, CCN4 and CCN5 secretion is directly linked to active Wnt signalling. CCN5 also represents a link between insulin and IGF-I regulation in islet function, and CCN5 overexpression leads to increased islet cell growth in vitro [46] . Interestingly, MSC NR exclusively secreted nephroblastoma overexpressed protein or NOV isoform (CCN3), which has been shown to impair beta cell proliferation and inhibit glucose-stimulated insulin secretion in vitro [45] . Thus, we predict modification of the ECM via Wnt-inducible CCN protein regulation is a critical step in islet regenerative processes.
One of the key differences between MSC R and MSC NR was the activation of Wnt signalling. Wnt signalling is highly conserved in primitive MSCs and is involved in multiple developmental processes, including cell proliferation, growth and fate determination. Aly and colleagues have shown that delivery of WNT3A and R-spondin to cultured islets increased the proliferation of adult human beta cells [47] . Our data suggests that MSC R propagate Wnt signalling primarily by autocrine secretion of WNT5A/B ligands with potential regulation by SFRP1. In contrast, MSC NR expressed proteins that inhibit Wnt signalling, namely DKK1 and DKK3. Although more research is required to determine potential effects of Wnt5 signalling on human beta cells, it is clear that MSC R maintain active canonical Wnt signalling and increase secretion of downstream effectors that promote beta cell regeneration. By inhibiting GSK3 activity using CHIR99201, we have shown that the activation of canonical Wnt pathway signals in MSC NR can mimic Wnt signalling allowing accumulation of nuclear β-catenin. Human pancreatic islets grown in media conditioned by MSC NR treated with CHIR99201 showed increased beta cell survival and proliferation during 7 days of culture. Manipulation of Wnt signalling through the inhibition of GSK3 has been previously suggested to directly increase beta cell proliferation. One study treated diabetic neonates with LiCl, a known inhibitor of GSK3, and doubled beta cell mass in rat models of diabetes [48] . Others have inhibited GSK3 using small molecules to regulate islet cell survival and proliferation in vitro [49] . Although, the mechanisms by which inhibition of GSK3 affects beta cell survival and proliferation in vivo is still unclear, our results suggest that activation of Wnt signalling in pancreasresident stromal cells may have practical application in beta cell regenerative therapies. Nonetheless, activation of Wnt signalling during MSC culture increased the regenerative capacity of MSC NR by altering downstream secretory patterns.
In summary, our data outlines several dynamic and complementary pathways that formulate a regenerative microenvironment applicable to the development of islet expansion therapies for diabetes using MSCs or their secretory products. The proteomic data reported in this study will be used in future studies to characterise functional mechanisms relevant to islet regeneration, or as screening technology to select MSC subpopulations that possess augmented capacity to regenerate islets in situ.
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